0001104659-22-127961.txt : 20221216 0001104659-22-127961.hdr.sgml : 20221216 20221216175916 ACCESSION NUMBER: 0001104659-22-127961 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221214 FILED AS OF DATE: 20221216 DATE AS OF CHANGE: 20221216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL JOSEPH CENTRAL INDEX KEY: 0001392297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40344 FILM NUMBER: 221469148 MAIL ADDRESS: STREET 1: 5 DICARLO ROAD CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akoya Biosciences, Inc. CENTRAL INDEX KEY: 0001711933 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 475586242 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE STREET 2: 6TH FLOOR CITY: MARLBOROUGH STATE: MA ZIP: 01762 BUSINESS PHONE: 855.896.8401 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE STREET 2: 6TH FLOOR CITY: MARLBOROUGH STATE: MA ZIP: 01762 4 1 tm2232955-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-12-14 0 0001711933 Akoya Biosciences, Inc. AKYA 0001392297 DRISCOLL JOSEPH 100 CAMPUS DRIVE,6TH FLOOR MARLBOROUGH MA 01762 0 1 0 0 Chief Financial Officer Common Stock 2022-12-14 4 M 0 10039 0.44 A 22539 D Common Stock 2022-12-14 4 S 0 10039 12.6693 D 12500 D Common Stock 2022-12-14 4 M 0 14574 0.44 A 27074 D Common Stock 2022-12-14 4 S 0 14574 12.4550 D 12500 D Employee Stock Option (Right to Buy) 0.44 2022-12-14 4 M 0 10039 0.00 D 2029-05-02 Common Stock 10039 123466 D Employee Stock Option (Right to Buy 0.44 2022-12-14 4 M 0 14574 0.00 D 2029-05-02 Common Stock 14574 108712 D Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.60 - $12.80. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein. Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.40 - $12.615. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein. Such performance-based option shares were issued in 2019. In 2020, the options vested as performance conditions were determined to have been achieved. /s/ Joseph Driscoll, by Brian McKelligon, as Attorney-in-Fact 2022-12-16